Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (593)	10/26/2004 12:01:45 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1336

Buying RYJUX again at the close today-- owned it last spring for awhile and, if I remember correctly, made a little money. This fund shorts treasuries and is a bet that rates will rise. My 64k portfolio, which is made up of tgen, sqnm, and lynx has melted down to about 52k over the past six months. I reduced my positions in those three microcap biotechs to buy Juno. After the recent recovery in Lynx, due to the merger news with Solexa, I am not actually taking a loss in the Lynx shares, so that is nice. I did take a minor loss in the shares of tgen I sold, and a significant loss in the sqnm--although I did not sell many shares there, I think Sequenom is cheap. Tgen is not cheap, Lynx is more confusing-- but it is still my largest position of the biotechs.